{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:15:21Z","timestamp":1790651721251,"version":"4.1.0"},"reference-count":121,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07048567"],"award-info":[{"award-number":["2018R1D1A1B07048567"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["SRC-2017R1A5A1014560"],"award-info":[{"award-number":["SRC-2017R1A5A1014560"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Epigenetic alterations have contributed greatly to human carcinogenesis. Conventional epigenetic studies have been predominantly focused on DNA methylation, histone modifications, and chromatin remodelling. Epitranscriptomics is an emerging field that encompasses the study of RNA modifications that do not affect the RNA sequence but affect functionality via a series of RNA binding proteins called writer, reader and eraser. Several kinds of epi-RNA modifications are known, such as 6-methyladenosine (m6A), 5-methylcytidine (m5C), and 1-methyladenosine. M6A modification is the most studied and has large therapeutic implications. In this review, we have summarised the therapeutic potential of m6A-modifiers in controlling haematological disorders, especially acute myeloid leukaemia (AML). AML is a type of blood cancer affecting specific subsets of blood-forming hematopoietic stem\/progenitor cells (HSPCs), which proliferate rapidly and acquire self-renewal capacities with impaired terminal cell-differentiation and apoptosis leading to abnormal accumulation of white blood cells, and thus, an alternative therapeutic approach is required urgently. Here, we have described how RNA m6A-modification machineries EEE (Editor\/writer: Mettl3, Mettl14; Eraser\/remover: FTO, ALKBH5, and Effector\/reader: YTHDF-1\/2) could be reformed into potential druggable candidates or as RNA-modifying drugs (RMD) to treat leukaemia. Moreover, we have shed light on the role of microRNAs and suppressors of cytokine signalling (SOCS\/CISH) in increasing anti-tumour immunity towards leukaemia. We anticipate, our investigation will provide fundamental knowledge in nurturing the potential of RNA modifiers in discovering novel therapeutics or immunotherapeutic procedures.<\/jats:p>","DOI":"10.3390\/biomedicines9060690","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:19:20Z","timestamp":1624015160000},"page":"690","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-2525","authenticated-orcid":false,"given":"Sunil","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"},{"name":"Science Research Center (SRC) for Immune Research on Non-lymphoid Organ (CIRNO), Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Nagpal","sequence":"additional","affiliation":[{"name":"Department of Nutrition & Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7398-0498","authenticated-orcid":false,"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medical Writer, Quebec City, QC G1X 3E1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-9424","authenticated-orcid":false,"given":"Muhammad Umer","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"},{"name":"Science Research Center (SRC) for Immune Research on Non-lymphoid Organ (CIRNO), Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2233-9449","authenticated-orcid":false,"given":"Yong-Soo","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"},{"name":"Science Research Center (SRC) for Immune Research on Non-lymphoid Organ (CIRNO), Sungkyunkwan University, Jangan-gu, Suwon 16419, Gyeonggi-do,  Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(74)90153-6","article-title":"Existence of methylated messenger RNA in mouse L cells","volume":"1","author":"Perry","year":"1974","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.febslet.2008.08.019","article-title":"Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO","volume":"582","author":"Jia","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nchembio1212-1008a","article-title":"Erratum: Corrigendum: N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"8","author":"Jia","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/d41573-019-00179-5","article-title":"Chemical inhibitors make their RNA epigenetic mark","volume":"18","author":"Cully","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ccell.2019.03.011","article-title":"The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells","volume":"35","author":"Jamieson","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_8","first-page":"2298","article-title":"Precise localization of m6A in rous sarcoma virus RNA reveals clustering of methylation sites: Implications for rna processing","volume":"5","author":"Kane","year":"1985","journal-title":"Mol. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3\u2032 UTRs and near Stop Codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"ref_10","first-page":"201","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_11","first-page":"38","article-title":"Acute myeloid leukemia: A review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R. I. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-020-00376-1","article-title":"New directions for emerging therapies in acute myeloid leukemia: The next chapter","volume":"10","author":"Daver","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Leisch, M., Jansko, B., Zaborsky, N., Greil, R., and Pleyer, L. (2019). Next generation sequencing in AML-on the way to becoming a new standard for treatment initiation and\/or modulation?. Cancers, 11.","DOI":"10.3390\/cancers11020252"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","article-title":"Mutations in AML: Prognostic and therapeutic implications","volume":"2016","author":"DiNardo","year":"2016","journal-title":"Hematology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.17219\/acem\/81610","article-title":"The new perspectives of targeted therapy in acute myeloid leukemia","volume":"28","author":"Walasek","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.beha.2019.05.002","article-title":"Novel monoclonal antibody-based therapies for acute myeloid leukemia","volume":"32","author":"Morsink","year":"2019","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.drudis.2019.08.006","article-title":"DNA methyltransferases: Emerging targets for the discovery of in-hibitors as potent anticancer drugs","volume":"24","author":"Yu","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yang, X., Wong, M.P.M., and Ng, R.K. (2019). Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184576"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17460441.2012.722618","article-title":"DNA methyltransferase inhibitors in acute myeloid leukemia: Discovery, design and first therapeutic expe-riences","volume":"7","author":"Thomas","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Con-version of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by mll partner tet1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fonc.2019.00417","article-title":"Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics","volume":"9","author":"Golub","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3324\/haematol.2020.266809","article-title":"Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia","volume":"106","author":"Zeng","year":"2021","journal-title":"Haematologica"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3346\/jkms.2021.36.e85","article-title":"Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies","volume":"36","author":"Lee","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2007-06-098061","article-title":"Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [saha]) in patients with advanced leukemias and myelodysplastic syndromes","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/CM9.0000000000000685","article-title":"Epigenetic therapies in acute myeloid leukemia: The role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors","volume":"133","author":"Xu","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"San Jose-Eneriz, E., Gimenez-Camino, N., Agirre, X., and Prosper, F. (2019). Hdac inhibitors in acute myeloid leukemia. Cancers, 11.","DOI":"10.3390\/cancers11111794"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","article-title":"Midostaurin approved for FLT3-mutated AML","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/10428194.2019.1660970","article-title":"CPX-351 (vyxeos) in AML","volume":"61","author":"Alfayez","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-18-2990","article-title":"FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia","volume":"25","author":"Krauss","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2014-10-608117","article-title":"Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia","volume":"125","author":"Dennis","year":"2015","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40265-019-1062-3","article-title":"Gilteritinib: First Global Approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40364-019-0170-2","article-title":"Correction to: Gilteritinib: A novel FLT3 inhibitor for acute myeloid leukemia","volume":"7","author":"Zhao","year":"2019","journal-title":"Biomark. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2019.05.008","article-title":"Venetoclax-based therapies for acute myeloid leukemia","volume":"32","author":"Guerra","year":"2019","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.3109\/10428194.2013.877134","article-title":"A phase 2 study of belinostat (pxd101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: A california cancer consortium study","volume":"55","author":"Kirschbaum","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"Santos","year":"2011","journal-title":"Leukemia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/leu.2017.242","article-title":"Phase I\/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)","volume":"31","author":"Bug","year":"2017","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"106197","DOI":"10.1016\/j.leukres.2019.106197","article-title":"Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia","volume":"85","author":"DeAngelo","year":"2019","journal-title":"Leuk. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1158\/1078-0432.CCR-19-0171","article-title":"Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results","volume":"25","author":"Wieduwilt","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood-2013-03-491506","article-title":"Sgn-cd33a: A novel cd33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant aml","volume":"122","author":"Walter","year":"2013","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"32532","DOI":"10.18632\/oncotarget.8687","article-title":"Phase i clinical study of rg7356, an anti-cd44 humanized antibody, in patients with acute myeloid leu-kemia","volume":"7","author":"Vey","year":"2016","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_44","first-page":"126","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood-2019-127962","article-title":"Pharmacological inhibition of the rna m6a writer mettl3 as a novel ther-apeutic strategy for acute myeloid leukemia","volume":"134","author":"Konstantinos","year":"2019","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.4435","article-title":"An epitranscriptomic vulnerability in myeloid malignancies","volume":"23","author":"Schmiechen","year":"2017","journal-title":"Nat. Med."},{"key":"ref_47","first-page":"2","article-title":"RNA Methyltransferases as a New Therapeutic Target in Leukemia","volume":"15","year":"2018","journal-title":"Hematologist"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small molecule inhibition of mettl3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"Mettl14 inhibits hema-topoietic stem\/progenitor differentiation and promotes leukemogenesis via mrna m(6)a modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1074\/jbc.M108476200","article-title":"Asb-2 inhibits growth and pro-motes commitment in myeloid leukemia cells","volume":"277","author":"Guibal","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6-Methyladenosine RNA Demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","article-title":"RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia","volume":"27","author":"Shen","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41422-018-0072-0","article-title":"Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nprot.2010.184","article-title":"Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells","volume":"6","author":"Choi","year":"2011","journal-title":"Nat. Protoc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s11427-015-4967-4","article-title":"Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq","volume":"58","author":"Zeng","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<147::AID-HON582>3.0.CO;2-3","article-title":"All-trans retinoic acid (atra) in the treatment of acute promyelocytic leukemia (apl)","volume":"14","author":"Chim","year":"1996","journal-title":"Hematol. Oncol."},{"key":"ref_58","first-page":"117","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0145-2126(92)90080-Q","article-title":"C-myc and c-myb ex-pression in acute myelogenous leukemia","volume":"16","author":"Gopal","year":"1992","journal-title":"Leuk. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-019-0252-2","article-title":"Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases","volume":"9","author":"Mundo","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref_61","first-page":"419","article-title":"Statistically significant expression of b-myb in clinically advanced human renal-cell carci-nomas","volume":"2","author":"Sakai","year":"1993","journal-title":"Int. J. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: The new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1947601910377495","article-title":"Myc Roles in Hematopoiesis and Leukemia","volume":"1","author":"Delgado","year":"2010","journal-title":"Genes Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood-2004-03-1074","article-title":"Retinoids and myelomonocytic growth factors cooperatively activate rara and induce human myeloid leukemia cell differentiation via map kinase pathways","volume":"105","author":"Glasow","year":"2005","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/bioinformatics\/btt171","article-title":"Exome-based analysis for RNA epigenome sequencing data","volume":"29","author":"Meng","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Mod-el-based analysis of chip-seq (macs)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zhang, M., Zhang, Y., Ma, J., Guo, F., Cao, Q., Zhang, Y., Zhou, B., Chai, J., Zhao, W., and Zhao, R. (2015). The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133788"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1073\/pnas.1820574116","article-title":"Structural insights into FTO\u2019s catalytic mechanism for the demethylation of multiple RNA substrates","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1586\/era.12.101","article-title":"All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia","volume":"12","author":"Masetti","year":"2012","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","article-title":"The success and the challenge of all-trans retinoic acid in the treatment of cancer","volume":"59","author":"Ni","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2014.06.021","article-title":"Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism","volume":"220","author":"Rubio","year":"2014","journal-title":"Chem. Interact."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-5793(01)02829-0","article-title":"ATRA-regulatedAsb-2gene induced in differentiation of HL-60 leukemia cells","volume":"505","author":"Kohroki","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1038\/bcj.2014.25","article-title":"Sensitivity of mll-rearranged aml cells to all-trans retinoic acid is associated with the level of h3k4me2 in the raralpha promoter region","volume":"4","author":"Sakamoto","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: From highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1087057115623264","article-title":"A radioactivity-based assay for screen-ing human m6a-rna methyltransferase, mettl3-mettl14 complex, and demethylase alkbh5","volume":"21","author":"Li","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Moroz-Omori, E.V., Huang, D., Bedi, R.K., Cheriyamkunnel, S.J., Bochenkova, E., Dolbois, A., Rzeczkowski, M.D., Wiedmer, L., \u015aled\u017a, P., and Caflisch, P. (2020). Mettl3 inhibitors for epitranscriptomic modulation of cellular processes. bio-Rxiv.","DOI":"10.1101\/2020.09.25.311803"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/acs.est.8b06173","article-title":"Potential consequences of regional species loss for global species richness: A quanti-tative approach for estimating global extinction probabilities","volume":"53","author":"Kuipers","year":"2019","journal-title":"Environ. Sci. Technol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG Exhibits Anti-tumor Activity by Targeting FTO\/m6A\/MYC\/CEBPA Signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.molcel.2020.05.027","article-title":"It\u2019s Not What You Say but How You Say It: Targeting RNA Methylation in AML","volume":"78","author":"Olsen","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting fto suppresses can-cer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Singh, B., Kinne, H.E., Milligan, R.D., Washburn, L.J., Olsen, M., and Lucci, A. (2016). Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159072"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/cn500042t","article-title":"Synthesis of a FTO Inhibitor with Anticonvulsant Activity","volume":"5","author":"Zheng","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMra1112635","article-title":"Targeting Epigenetic Readers in Cancer","volume":"367","author":"Dawson","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_87","first-page":"529","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature14888","article-title":"Bet in-hibitor resistance emerges from leukaemia stem cells","volume":"525","author":"Fong","year":"2015","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1002\/anie.200453879","article-title":"Design, Synthesis, and Biological Evaluation of a Small-Molecule Inhibitor of the Histone Acetyltransferase Gcn5","volume":"43","author":"Biel","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","article-title":"A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia","volume":"17","author":"Tzelepis","year":"2016","journal-title":"Cell Rep."},{"key":"ref_91","first-page":"818","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL\u2013AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAI.0000000000000392","article-title":"Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis","volume":"26","author":"Song","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"24163","DOI":"10.18632\/oncotarget.4643","article-title":"TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1534\/g3.119.400361","article-title":"TNF-\u03b1 Differentially Regulates Cell Cycle Genes in Promyelocytic and Granulocytic HL-60\/S4 Cells","volume":"9","author":"Jacobson","year":"2019","journal-title":"Genes Genomes Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Tan, S.H., Bertulfo, F.C., and Sanda, T. (2017). Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00218"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mapperley, C., Van De Lagemaat, L.N., Lawson, H., Tavosanis, A., Paris, J., Campos, J., Wotherspoon, D., Durko, J., Sarapuu, A., and Choe, J. (2021). The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. J. Exp. Med., 218.","DOI":"10.1084\/jem.20200829"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.molcel.2019.02.021","article-title":"ADAR1: A New Target for Immuno-oncology Therapy","volume":"73","author":"Bhate","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature25434","article-title":"Tet2 promotes pathogen infec-tion-induced myelopoiesis through mrna oxidation","volume":"554","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1038\/cddis.2016.256","article-title":"miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways","volume":"7","author":"Fang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/1568026621666210303150235","article-title":"Therapeutic Potential of microRNA Against Th2-associated Immune Disorders","volume":"21","author":"Kumar","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"109878","DOI":"10.1016\/j.biopha.2020.109878","article-title":"Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a\/MYCN axis","volume":"125","author":"Cao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4161\/cc.8.8.8126","article-title":"Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?","volume":"8","author":"Ferrandiz","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-019-1187-z","article-title":"Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells","volume":"10","author":"Melnik","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13046-019-1179-y","article-title":"Mir-29b\/sp1\/fut4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via wnt\/beta-catenin pathway in acute myeloid leukemia","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1084\/jem.20150304","article-title":"Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance","volume":"212","author":"Palmer","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni.3470","article-title":"CIS is a potent checkpoint in NK cell\u2013mediated tumor immunity","volume":"17","author":"Delconte","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e1267892","DOI":"10.1080\/2162402X.2016.1267892","article-title":"Tar-geting cytokine signaling checkpoint cis activates nk cells to protect from tumor initiation and metastasis","volume":"6","author":"Putz","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature23450","article-title":"M(6)a mrna methyl-ation controls t cell homeostasis by targeting the il-7\/stat5\/socs pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/icb.2017.67","article-title":"Writer\u2019s block: Preventing m 6 A mRNA methylation promotes T cell naivety","volume":"95","author":"Sprent","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"ref_112","unstructured":"Yan, J., Barr, T., Zhang, J., Chen, Z., Wang, L.S., Sun, J.C., Sun, J.C., Chen, J., Caligiuri, M.A., and Yu, J. (2021). The rna m6a reader ythdf2 controls nk cell anti-tumor and anti-viral immunity. bioRxiv."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic reprograming via deletion of cish in human ipsc-derived nk cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Kumar, S., Jeong, Y., Ashraf, M.U., and Bae, Y.-S. (2019). Dendritic Cell-Mediated Th2 Immunity and Immune Disorders. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201904.0007.v1"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e23404","DOI":"10.4161\/onci.23404","article-title":"Regulation of dc development and dc-mediated t-cell immunity via cish","volume":"2","author":"Miah","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1684\/bdc.2012.1587","article-title":"Dendritic cell-based therapeutic vaccination for acute myeloid leukemia","volume":"99","author":"Anguille","year":"2012","journal-title":"Bull. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1038\/bcj.2017.67","article-title":"Clini-co-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia","volume":"7","author":"Hou","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1038\/cddis.2017.244","article-title":"MYBL2 (B-Myb): A central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis","volume":"8","author":"Musa","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.2147\/OTT.S283417","article-title":"The potential role of n6-methyladenosine (m6a) demethylase fat mass and obesity-associated gene (fto) in human cancers","volume":"13","author":"Wang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med., 368, 2059\u20132074.","DOI":"10.1056\/NEJMoa1301689"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Schaefer, M., Kapoor, U., and Jantsch, M.F. (2017). Understanding RNA modifications: The promises and technological bottlenecks of the \u2018epitranscriptome\u2019. Open Biol., 7.","DOI":"10.1098\/rsob.170077"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/690\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:18:33Z","timestamp":1760163513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":121,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biomedicines9060690"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9060690","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202105.0193.v1","asserted-by":"object"}]},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]}}}